Nocturnal Gastroesophageal Reflux Revisited by Impedance-pH Monitoring

por Fornari, Fernando, Blondeau, Kathleen, Mertens, Veerle, Tack, Jan, Sifrim, Daniel
Publicado 2011

Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks

por Guthrie, Heather, Honig, Lawrence S., Lin, Helen, Sink, Kaycee M., Blondeau, Kathleen, Quartino, Angelica, Dolton, Michael, Carrasco-Triguero, Montserrat, Lian, Qinshu, Bittner, Tobias, Clayton, David, Smith, Jillian, Ostrowitzki, Susanne
Publicado 2020

Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials

por Ostrowitzki, Susanne, Bittner, Tobias, Sink, Kaycee M., Mackey, Howard, Rabe, Christina, Honig, Lawrence S., Cassetta, Emanuele, Woodward, Michael, Boada, Mercè, van Dyck, Christopher H., Grimmer, Timo, Selkoe, Dennis J., Schneider, Andres, Blondeau, Kathleen, Hu, Nan, Quartino, Angelica, Clayton, David, Dolton, Michael, Dang, Yifan, Ostaszewski, Beth, Sanabria-Bohórquez, Sandra M., Rabbia, Michael, Toth, Balazs, Eichenlaub, Udo, Smith, Jillian, Honigberg, Lee A., Doody, Rachelle S.
Publicado 2022